4 results on '"Wang, Rong-Hsuan"'
Search Results
2. The Hidden Role of Hydrogen Sulfide Metabolism in Cancer.
- Author
-
Wang, Rong-Hsuan, Chu, Yu-Hsin, and Lin, Kai-Ti
- Subjects
- *
HYDROGEN sulfide , *CANCER invasiveness , *ENZYME metabolism , *METABOLISM , *CANCER treatment , *VASODILATION , *NEOVASCULARIZATION - Abstract
Hydrogen Sulfide (H2S), an endogenously produced gasotransmitter, is involved in various important physiological and disease conditions, including vasodilation, stimulation of cellular bioenergetics, anti-inflammation, and pro-angiogenesis. In cancer, aberrant up-regulation of H2S-producing enzymes is frequently observed in different cancer types. The recognition that tumor-derived H2S plays various roles during cancer development reveals opportunities to target H2S-mediated signaling pathways in cancer therapy. In this review, we will focus on the mechanism of H2S-mediated protein persulfidation and the detailed information about the dysregulation of H2S-producing enzymes and metabolism in different cancer types. We will also provide an update on mechanisms of H2S-mediated cancer progression and summarize current options to modulate H2S production for cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Dysregulation of cystathionine γ‐lyase promotes prostate cancer progression and metastasis.
- Author
-
Wang, Yi‐Hsiang, Huang, Jo‐Ting, Chen, Wen‐Ling, Wang, Rong‐Hsuan, Kao, Ming‐Chien, Pan, Yan‐Ru, Chan, Shih‐Hsuan, Tsai, Kuo‐Wang, Kung, Hsing‐Jien, Lin, Kai‐Ti, and Wang, Lu‐Hai
- Abstract
Hydrogen sulfide (H2S), an endogenous signaling gaseous molecule, is involved in various physiological activities, including vessel relaxation, regulation of cellular bioenergetics, inflammation, and angiogenesis. By using xenograft orthotopic implantation of prostate cancer PC3 cells and subsequently comparing bone metastatic with primary tumor‐derived cancer cells, we find that H2S‐producing enzyme cystathionine γ‐lyase (CTH) is upregulated in bone‐metastatic PC3 cells. Clinical data further reveal that the expression of CTH is elevated in late‐stage prostate cancer patients, and higher CTH expression correlates with poor survival from The Cancer Genome Atlas (TCGA) prostate cancer RNA‐seq datasets. CTH promotes NF‐κB nuclear translocation through H2S‐mediated sulfhydration on cysteine‐38 of the NF‐κB p65 subunit, resulting in increased IL‐1β expression and H2S‐induced cell invasion. Knockdown of CTH in PC3 cells results in the suppression of tumor growth and distant metastasis, while overexpression of CTH in DU145 cells promotes primary tumor growth and lymph node metastasis in the orthotopic implanted xenograft mouse model. Together, our findings provide evidence that CTH generated H2S promotes prostate cancer progression and metastasis through IL‐1β/NF‐κB signaling pathways. Synopsis: Cystathionine‐γ‐lyase (CTH) and its catalyzed product hydrogen sulfide, a known gaseous transmitter, are dysregulated in prostate cancer. Increased CTH activity promotes cancer progression and metastasis via the sulfhydration of the NF‐κB subunit p65. CTH induces H2S production to stimulate the sulfhydration of p65, promoting its nuclear translocation.CTH‐dependent p65 sulfhydration triggers cell invasion via IL‐1β mediated signaling.CTH promotes tumor growth, angiogenesis and lymphangiogenesis and distant metastasis in vivo.CTH levels are elevated in late‐stage prostate cancer patients and negatively correlated with good prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Effects of synthetic glucocorticoids on breast cancer progression.
- Author
-
Pang, Jia Meng, Huang, Yi-Chen, Sun, Shu-Pin, Pan, Yan-Ru, Shen, Chia-Yi, Kao, Ming-Chien, Wang, Rong-Hsuan, Wang, Lu-Hai, and Lin, Kai-Ti
- Subjects
- *
METASTATIC breast cancer , *CANCER invasiveness , *CANCER cell growth , *BREAST cancer , *STEROID receptors , *METASTASIS - Abstract
• Low-dose GCs suppress breast tumor growth and metastases in two breast cancer xenograft mouse models. • High-dose GCs enhance breast tumor growth and metastases in two breast cancer xenograft mouse models. • DEX suppress cell adhesion, migration, and invasion in a dose-dependent manner in multiple breast cancer cell lines. Glucocorticoids (GCs) are widely prescribed as adjuvant therapy for breast cancer patients. Unlike other steroid hormone receptors, the GC receptor is not considered an oncogene. Research in the past few years has revealed the complexity of GC-mediated signaling, but it remains puzzling whether GCs promote or inhibit tumor progression in different cancer types. Here we evaluated the potential of using a synthetic GC, dexamethasone (DEX), in the treatment of breast cancer. We found that the administration of low-dose DEX suppressed tumor growth and distant metastasis in the MCF-7 and MDA-MB-231 xenograft mouse model, whereas treatment with high-dose DEX enhanced tumor growth and metastasis, respectively. Treatment of breast cancer cells with DEX inhibited cell adhesion, migration, and invasion in a dose-dependent manner. The DEX-mediated inhibition of cell adhesion, migration, and invasion is partly through induction of microRNA-708 and subsequent Rap1B-mediated signaling in MDA-MB-231 cells. On the other hand, in MCF-7 cells, DEX-suppressed cell migration is independent from microRNA-708 mediated signaling. Overall, our data reveal that DEX acts as a double-edged sword during breast-cancer progression and metastasis: Lower concentrations inhibit breast cancer tumor growth and metastasis, whereas higher concentrations may play an undesired role to promote breast cancer progression. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.